Tag Archives: Drug Delivery

Dr. Gerallt Williams, Director Scientific Affairs, Aptar Pharma

Leave a comment

Dr. Gerallt WilliamsAfter obtaining his Ph.D. from the University of Wales, UK in 1985, Gerallt has held various industrial positions at Monsanto Inc. (UK), Fisons Ltd (UK), Valois (France) and Inhale/Nektar Therapeutics (USA).

Gerallt is now in charge of scientific affairs for the Aptar Pharma Prescription division, Le Vaudreuil, France and is engaged in the development of new devices for nasal, inhaled and injectable drug products.

What made you partner with Business Review Webinars?

Aptar Pharma wanted to reach out to a more global audience in order to share our enthusiasm about intra-nasal drug delivery which is a relatively new drug delivery approach and creating a webinar in partnership with BRW offered us the possibility to achieve this goal.

What do you enjoy the most about your role?

Developing new products that will hopefully bring some relief to patients suffering with difficult medical conditions is ultimately what we are trying to do day in and day out in our roles in the drug delivery industry – the enjoyment is in the journey.

What is your favourite place in the world and why?

I’m Welsh and I’ve been living in various countries during my career including Wales where I was born and grew up, England, the US and France. I feel well in France because I can enjoy a variety of unique experiences … while being so close to the UK!

What about nasal drug delivery are you most looking forward to sharing with the audience?

Although nasal drug delivery is somewhat of a niche area in the pharmaceutical industry we hope to share with the audience the future potential of this drug delivery approach, how ground-breaking and innovative research is being pursued with the possibility to open up a brand new way to treat some very serious and debilitating conditions which are predicted to become more prevalent over the coming decades.  Intranasal route is simple to access and non-invasive, it can be versatile (self-administration vs third-party’s-administration) and used for local and systemic/CNS nose-to-brain treatments – “The nose is the only natural corridor where the brain meets the outside world”.

What do you hope the audience will learn from this webinar?

The webinar is part educational, part setting the scene in the market place and part science and technology. Hopefully the audience will find some new information by participating in the webinar and may be able to identify opportunities for developing products for some of the unmet medical needs in this area via the nasal drug delivery approach.

Join Dr. Williams in the upcoming Aptar Pharma webinar: The Nasal Drug Delivery Journey: from Systemic to Nose-to-Brain? Register Now!

Catalent Microsite: Resources for Solving Drug Delivery, Clinical Supply and Biologic Challenges

Leave a comment

Catalent has recently launched their newCatalent_Image microsite within Business Review Webinars.

The site features recent Webinars, Videos and Case Studies detailing research across the full spectrum of challenges that pharmaceutical companies face with their pipeline molecules. Catalent is focused on helping their customers get more molecules to market by enhancing product performance and providing superior, reliable manufacturing results.

To learn more, please click here to be brought directly to the microsite.

Kevin J. Wrigley, Product and Service Manager, Vetter Pharma International GmbH

Leave a comment

Kevin J. Wrigley

Kevin J. Wrigley earned his MSc in International Business from the University of Ulster, UK in 2009. At Vetter, he is responsible for managing the commercial manufacturing business as it pertains to the product lifecycle and portfolio management perspective. Kevin began his career in the medical device and pharmaceutical industries in management positions at Smith & Nephew, and MorphoSys. He joined Vetter International in 2013 as Product & Service Manager.

1.      Why did you decide to do a webinar with Business Review Webinars?
Webinars are an important vehicle for helping us reach our target audiences with key messages. Given our positive experience with webinars in the past, it is to our advantage to continue participating in them. We see Business Review Webinars as the right partner to help deliver our messages to the market.

2.      What are you looking forward to explaining to the audience?
We would like to educate audiences to the trends that are occurring in the pharmaceutical industry, and what to consider when choosing a drug delivery system. In particular, we would like to make them aware of the options available with prefilled syringes.

3.      How did you get into the industry and what do you most enjoy about your role?
I started working in the industry in the area of drug discovery, followed by positions in medical technology, and drug development. I am fascinated by the ever-changing nature of the industry. My current position offers me a great deal of satisfaction as I have the opportunity to interact with a wide-variety of internal and external stakeholders.

4.      Football or tennis?
I like both sports, though I am but a spectator in football and a more talented in playing tennis.

5.       What would someone be surprised to know about you?
I see myself as a cosmopolitan; living & working in so many different places that I feel the world as a whole is my home!

Don’t forget to join the upcoming Vetter Pharma webinar titled ‘Packaging challenges for prefilled syringes in a growing biologics market‘ on November 17th. Register here.